# Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease

> **NCT05576818** · PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 66 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers

## Key facts

- **NCT ID:** NCT05576818
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-30
- **Primary completion:** 2025-06
- **Final completion:** 2025-06
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05576818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05576818, "Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05576818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*